CYCLIN-DEPENDENT KINASE 2

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 23:50:56 GMT 2025` Edited by `admin` on `Tue Apr 01 23:50:56 GMT 2025`
Protein Type	ENZYME
Protein Sub Type	SERINE/THREONINE-PROTEIN KINASE
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	IEQ8K30M47
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CYCLIN-DEPENDENT KINASE 2

Common Name

English

CDKN2

Preferred Name

English

P33 PROTEIN KINASE

Common Name

English

CDK2

Common Name

English

CELL DIVISION PROTEIN KINASE 2

Common Name

English

Code System Code Type Description

FDA UNII

IEQ8K30M47

Created by admin on Tue Apr 01 23:50:56 GMT 2025 , Edited by admin on Tue Apr 01 23:50:56 GMT 2025

PRIMARY

UNIPROT

P24941

Created by admin on Tue Apr 01 23:50:56 GMT 2025 , Edited by admin on Tue Apr 01 23:50:56 GMT 2025

PRIMARY

Related Record Type Details


					688000M8S8

MILCICLIB

INHIBITOR -> TARGET

Amount:


					X1BF92PW9T

AT-7519

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					6MC966B505

FN-1501

INHIBITOR -> TARGET


					45AD6X575G

ALVOCIDIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					U93X72ED47

Certociclib

INHIBITOR -> TARGET

Amount:


					63Q7F59W0V

ATUVECICLIB

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:


					0ES1C2KQ94

SELICICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					1GAJ98SC2X

RGB-286638 FREE BASE

INHIBITOR -> TARGET

Amount:


					29713BMI56

ZK-304709

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					Z6BYC0F36E

AVOTACICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					4V8ECV0NBQ

DINACICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					FD2SWT2SDI

SU-9516

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					MKS45S912B

PHA-793887

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					Q6460P4C0B

Inixaciclib

INHIBITOR -> TARGET

Amount:


					3B512HJD65

EBVACICLIB

INHIBITOR -> TARGET

Amount:


					YET2XNU791

FADRACICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					2QD8YT8RWZ

INX-315

INHIBITOR -> TARGET

Comments:

Selective inhibitor

Amount:


					40D08182TT

ZOTIRACICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					9979I93686

SNS-032

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					0W9Q8U337A

RONICICLIB

INHIBITOR -> TARGET

Comments:

The development of bronchopulmonary hemorrhage and sepsis resulted in the death of two patients. The study was ultimately terminated prematurely due to an unfavorable risk-benefit ratio in patients.

Qualification:

IC50

Amount:


					9EK26WE8QN

RIVICICLIB

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION	[1_14] [1_160]	SITE_SPECIFIC	THREONINE PHOSPHATE	3L4WX7B1EI
AMINO_ACID_SUBSTITUTION	[1_15] [1_19]	SITE_SPECIFIC	TYROSINE O-PHOSPHATE	2R86C98KDX
AMINO_ACID_SUBSTITUTION	[1_6]	SITE_SPECIFIC	N6-ACETYLLYSINE	470AD5VY1X
AMINO_ACID_SUBSTITUTION	[1_1]	SITE_SPECIFIC	N-ACETYLMETHIONINE	9J12WX5B6A

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL